MX2, A MORPHOLINO ANTHRACYCLINE, AS A NEW ANTITUMOR AGENT AGAINST DRUG-SENSITIVE AND MULTIDRUG-RESISTANT HUMAN AND MURINE TUMOR-CELLS

被引：0
|
作者：
WATANABE, M
KOMESHIMA, N
NAKAJIMA, S
TSURUO, T
机构：
[1] JAPANESE FDN CANC RES,CTR CANC CHEMOTHERAPY,KAMI IKEBUKURO,TOSHIMA KU,TOKYO 170,JAPAN
[2] KIRIN BREWERY CO LTD,PHARMACEUT LAB,MAEBASHI,GUNMA 371,JAPAN
来源：
CANCER RESEARCH | 1988年 / 48卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6653 / 6657
页数：5
相关论文
共 30 条
  • [1] CELLULAR PHARMACOLOGY OF MX2, A NEW MORPHOLINO ANTHRACYCLINE, IN HUMAN PLEIOTROPIC DRUG-RESISTANT CELLS
    WATANABE, M
    KOMESHIMA, N
    NAITO, M
    ISOE, T
    OTAKE, N
    TSURUO, T
    CANCER RESEARCH, 1991, 51 (01) : 157 - 161
  • [2] Sensitizing properties of new N-(2-arylalkyl) propionamides in drug-sensitive and multidrug-resistant tumor cells
    Ros, F
    Garcia, R
    RiveraFillat, MP
    Gonzalez, MA
    GrauOliete, MR
    ARCHIV DER PHARMAZIE, 1995, 328 (11-12) : 755 - 758
  • [3] A FLUORINE-CONTAINING ANTHRACYCLINE (ME2303) AS A NEW ANTITUMOR AGENT AGAINST MURINE AND HUMAN-TUMORS AND THEIR MULTIDRUG-RESISTANT SUBLINES
    TSURUO, T
    YUSA, K
    SUDO, Y
    TAKAMORI, R
    SUGIMOTO, Y
    CANCER RESEARCH, 1989, 49 (20) : 5537 - 5542
  • [4] THE ANTITUMOR EFFECT OF MX2, A NEW MORPHOLINO ANTHRACYCLINE, AGAINST MALIGNANT GLIOMA CELL-LINES AND ITS SUBCELLULAR-DISTRIBUTION
    KABUTO, M
    KUBOTA, T
    KOBAYASHI, H
    NAKAGAWA, T
    KITAI, R
    NEUROSURGERY, 1995, 37 (03) : 471 - 476
  • [5] RHIZOXIN, A MACROCYCLIC LACTONE ANTIBIOTIC, AS A NEW ANTITUMOR AGENT AGAINST HUMAN AND MURINE TUMOR-CELLS AND THEIR VINCRISTINE-RESISTANT SUBLINES
    TSURUO, T
    OHHARA, T
    IIDA, H
    TSUKAGOSHI, S
    SATO, Z
    MATSUDA, I
    IWASAKI, S
    OKUDA, S
    SHIMIZU, F
    SASAGAWA, K
    FUKAMI, M
    FUKUDA, K
    ARAKAWA, M
    CANCER RESEARCH, 1986, 46 (01) : 381 - 385
  • [6] THE ANTITUMOR EFFECT OF MX2, A NEW MORPHOLINO ANTHRACYCLINE, AGAINST MALIGNANT GLIOMA CELL-LINES AND ITS SUBCELLULAR-DISTRIBUTION - COMMENTS
    SAWAYA, R
    NEUROSURGERY, 1995, 37 (03) : 476 - 477
  • [7] Cytotoxic activity of medicinal plants of the Kakamega County (Kenya) against drug-sensitive and multidrug-resistant cancer cells
    Ochwang'i, Dominic O.
    Kimwele, Charles N.
    Oduma, Jemimah A.
    Gathumbi, Peter K.
    Kiama, Stephen G.
    Efferth, Thomas
    JOURNAL OF ETHNOPHARMACOLOGY, 2018, 215 : 233 - 240
  • [8] CYTOPLASMIC MEMBRANE CHOLESTEROL AND DOXORUBICIN CYTOTOXICITY IN DRUG-SENSITIVE AND MULTIDRUG-RESISTANT HUMAN OVARIAN-CANCER CELLS
    MAZZONI, A
    TRAVE, F
    ONCOLOGY RESEARCH, 1993, 5 (02) : 75 - 82
  • [9] Sugar amino acid containing somatostatin analogues that induce apoptosis in both drug-sensitive and multidrug-resistant tumor cells
    Gruner, SAW
    Kéri, G
    Schwab, R
    Venetianer, A
    Kessler, H
    ORGANIC LETTERS, 2001, 3 (23) : 3723 - 3725
  • [10] Increase in therapeutic index of doxorubicin and vinblastine by aptameric oligonucleotide in human T lymphoblastic drug-sensitive and multidrug-resistant cells
    Dapas, B
    Perissin, L
    Pucillo, C
    Quadrifoglio, F
    Scaggiante, B
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2002, 12 (04): : 247 - 255
123